Catalyst Wire Dossier Catalyst Wire Dossier

CAIV-T (influenza vaccine, live attenuated)

Influenza vaccine, live attenuated · MedImmune LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAIV-T (influenza vaccine, live attenuated), covering 2006-10-03 to 2006-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children [Phase 3]

See pricing